OneSkin

OneSkin is a biotechnology company founded in 2016 by four Brazilian PhD scientists specializing in skin regeneration and related fields. The company focuses on skin longevity and rejuvenation by addressing the root causes of skin aging at the molecular and cellular levels. OneSkin has developed a proprietary molecular clock called MolClock, which measures the skin’s molecular age based on DNA methylation, allowing for a quantitative assessment of skincare product efficacy.

OneSkin creates science-backed topical skincare products aimed at reversing skin aging by targeting cellular senescence. Their flagship ingredient, OS-01, is a patented peptide that reduces the accumulation of senescent cells, improving skin appearance and function. The product line includes advanced sun protection formulations that combine OS-01 with antioxidants and non-nano zinc oxide. OneSkin emphasizes rigorous research and development, conducting clinical studies and publishing peer-reviewed research to validate their claims. The company is positioned as a leader in science-driven topical skin longevity treatments, appealing to consumers seeking effective anti-aging solutions.